# Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients

> **NCT01435174** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 17 (actual)

## Conditions studied

- End-stage Renal Disease
- Cardiovascular Disease

## Interventions

- **DRUG:** Ranolazine
- **PROCEDURE:** Pharmacokinetic Blood and Dialysate Sampling
- **PROCEDURE:** QT Interval

## Key facts

- **NCT ID:** NCT01435174
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435174, "Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01435174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*